Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Meet The Company That Is Giving Consumers Back Control of Their Own Data

(Click image to watch video) With offices in Toronto and New York, Killi Ltd. ( TSXV: MYID , OTCQB: MYIDD , Forum ) is a Canadian-based data company focused on data protection and privacy by allowing consumers to take back control of their data from those wh...
Jocelyn Aspa | May 11, 2021 |

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...
Streetwise Reports | November 19, 2019 |

Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study

Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients. Clinical-stage biotechnology...
Streetwise Reports | July 2, 2020 |

Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug

Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...
Streetwise Reports | December 27, 2019 |

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...
Streetwise Reports | August 28, 2019 |

The Dales Report panelists agree on this vote: Way to go, Ohio

Welcome to the Trade To Black podcast on Stockhouse.com . In the episode in the above video, Shadd Dales, Anthony Varrell and Benjamin Smith talk in-depth about the following stories and more: Ohio voters approve the legalization of adult use cannabis ...
The Dales Report | November 9, 2023 |

ICAN Leverages Leading California Brand with Expansion into Nevada, ...

ICAN Leverages Leading California Brand with Expansion into Nevada, Introduces State-of-the-Art Pre-Roll Machine, for Aggressive Near-Term Growth A recent acquisition is helping this company to expand its brand. If a customer at any of the popular recreational ...
Streetwise Reports | November 21, 2019 |

Buzz on the Bullboards: Stocks Making the Most of the Fall Season

Following news that it expects revenue for Q3 2021 to be at least $8 million, resulting in total revenue for the nine months ended September 30, 2021 of at least $22 million (twice as much as that period, last year), PyroGenesis Canada Inc. ( TSX-V.PYR , Forum ) announ...
Stockhouse Editorial | November 3, 2021 |

10 Million Americans Applied for Unemployment Benefits. Will Gold Save the Day?

In just two weeks of March, around 10 million Americans applied for unemployment benefits. That’s more than during the Great Recession. What does it imply for the US economy and the gold market? US Labor Market Sinks In the previous edition of the Fundam...
Arkadiusz Sieron | April 7, 2020 |

30 Million of Americans Applied for Unemployment Benefit. Should They Buy Gold?

Just like the BoJ last week, the ECB also expanded its monetary policy easing. Meanwhile across the pond, more than 30 million of Americans applied for the unemployment benefit. What does it all means for the gold market? European Central Banks Expands Its Monetary Policy E...
Arkadiusz Sieron | May 5, 2020 |
1 2 3 4 5 6 7 8 9 10 ...